Further analysis showed that patients with advanced disease (III+IV) had higher concentrations of NLRP6 than patients with early disease (I+II), which indicated that NLRP6 was related to the occurrence of macular degeneration and the progressive stage of the disease. Here, NLRP6 is linked to macular degeneration.